summer_banner_0.jpg
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations

Pharmaceutical company invests in new vaccine manufacturing plant in southwest Montana

Minnesota has administered about 39% of the vaccine doses it has received. About 1.5% of the state's population has been vaccinated.
Pascal Guyot
/
AFP via Getty Images
New Jersey-based Tonix Pharmaceuticals plans to build a vaccine manufacturing facility in Hamilton.

Plans to build a vaccine manufacturing facility in southwest Montana are moving forward.

New Jersey-based Tonix Pharmaceuticals expects to employ around 120 people at the new facility in Ravalli County.

This is the company’s first investment in Montana. CEO Seth Lederman says the company chose Hamilton because of the biotech activity happening there.

“We were attracted to Montana because Hamilton is home of the Rocky Mountain National Laboratory, which is a 90-year-old world renowned infectious disease and vaccine research institute,” he said.

GlaxoSmithKline also operates one of its vaccine manufacturing facilities in Hamilton.

Tonix Pharmaceuticals plans to manufacture live vaccines out of the new facility. Lederman says that could include a COVID-19 vaccine and one for smallpox and monkeypox the company is currently developing. He anticipates the new facility to be operational in 2025.

Olivia Weitz covers Bozeman and surrounding communities in Southwest Montana for Yellowstone Public Radio. She has reported for Northwest News Network and Boise State Public Radio and previously worked at a daily print newspaper. She is a graduate of the University of Puget Sound and the Transom Story Workshop.